Supplementary Table 1 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models

Naoto Miyajima,Shinji Tsutsumi,Carole Sourbier,Kristin Beebe,Mehdi Mollapour,Candy Rivas,Soichiro Yoshida,Jane B. Trepel,Ying Huang,Manabu Tatokoro,Nobuo Shinohara,Katsuya Nonomura,Len Neckers

crossref（2023）

引用 0|浏览11

暂无评分

摘要

PDF file - 6K, Crizotinib and ganetespib synergistically inhibit colony growth of NIH3T3 cells expressing constitutively active, TKI-resistant MET (MET-Y1248H).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要